Jacob Asset Management Of New York LLC Harrow Health, Inc. Transaction History
Jacob Asset Management Of New York LLC
- $70.6 Million
- Q3 2023
A detailed history of Jacob Asset Management Of New York LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Jacob Asset Management Of New York LLC holds 91,779 shares of HROW stock, worth $2.97 Million. This represents 1.87% of its overall portfolio holdings.
Number of Shares
91,779
Previous 85,164
7.77%
Holding current value
$2.97 Million
Previous $1.62 Million
18.69%
% of portfolio
1.87%
Previous 1.84%
Shares
12 transactions
Others Institutions Holding HROW
# of Institutions
176Shares Held
21.3MCall Options Held
845KPut Options Held
717K-
Opaleye Management Inc. Boston, MA3.99MShares$129 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$70 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$69.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$60.4 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$23.6 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $876M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...